Segmed

Segmed operates a technology-enabled data platform that aggregates and provides structured, de-identified medical imaging data from a diverse, global network of over 2,800 healthcare sites, encompassing more than 150 million imaging studies. The company serves pharmaceutical, medical device, and AI developers by offering fit-for-purpose datasets for R&D, algorithm training, and regulatory validation, with its data having contributed to over 45 FDA-cleared products. As a private, revenue-generating platform company, Segmed addresses critical bottlenecks in medical AI development by ensuring data diversity, quality, and regulatory compliance, positioning itself as a key infrastructure provider in the growing real-world data ecosystem.

Proprietary self-serve platform (Openda) for aggregating, de-identifying, structuring, and providing query-based access to millions of regulatory-grade, multimodal medical imaging studies and associated data from a global network of healthcare providers.

Segmed competes with other medical imaging data brokers (e.g., Flywheel, MD.ai partners), large contract research organizations (CROs) with data divisions, and direct collaborations between AI developers and hospital systems. Its differentiation lies in its self-serve platform focus, emphasis on regulatory-grade data for product clearance, and its large, diverse, and instantly queryable dataset.